Palisade Bio shares are trading higher after the company announced it received a European patent titled 'Stable Neural Stem Cells Comprising An Exogenous Polynucleotide Coding For A Growth Factor And Methods Of Use Thereof'
Portfolio Pulse from Benzinga Newsdesk
Palisade Bio announced that it has received a European patent for 'Stable Neural Stem Cells Comprising An Exogenous Polynucleotide Coding For A Growth Factor And Methods Of Use Thereof'. This has led to an increase in the company's share price.
May 24, 2023 | 4:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Palisade Bio's shares are trading higher after receiving a European patent for stable neural stem cells.
The European patent for stable neural stem cells is a significant development for Palisade Bio. This news has a direct impact on the company's share price, as it demonstrates the company's progress in the biotech sector and its ability to secure intellectual property rights. The patent may lead to new opportunities and potential revenue streams for the company, which is why the share price has increased.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100